Showing results (61-70 of 99) with videos related to
Sort By:
Pageof 10
Nature Communications|August 4, 2023
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancerQiming Zhou, Yao Peng, Fenfen Ji, et al.Theranostics|October 8, 2019
VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6Yujuan Dong, Yanquan Zhang, Wei Kang, et al.Oncogene|October 8, 2021
CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancerShanshan Gao, Fraser Soares, Shiyan Wang, et al.Oncogene|April 2, 2026
Strand-asymmetric G-runs and G4s downstream of TSS modulate tumor suppressor gene transcriptionDan Huang, Xiaoting Zhang, Xiansong Wang, et al.Cancer Research|June 20, 2024
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal TumorigenesisDanyu Chen, Fenfen Ji, Qiming Zhou, et al.Cancer Research|April 26, 2019
TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin SignalingHongyan Gou, Jessie Qiaoyi Liang, Lijing Zhang, et al.Gastroenterology|November 20, 2020
RNA N<sup>6</sup>-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m<sup>6</sup>A-GLUT1-mTORC1 Axis and Is a Therapeutic TargetHuarong Chen, Shanshan Gao, Weixin Liu, et al.Science Translational Medicine|April 20, 2018
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical targetDabin Liu, Chi Chun Wong, Li Fu, et al.Gastroenterology|October 20, 2023
High Soluble Fiber Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites in MiceJia Yang, Hong Wei, Yufeng Lin, et al.Cell Reports. Medicine|August 16, 2023
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapyYasi Pan, Huarong Chen, Xiang Zhang, et al.Pageof 10